Key facts
- This page summarizes Julia P. Gregory's Form 4 filing for Nurix Therapeutics, Inc. (NRIX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Sep 2025, 18:58.
Julia P. Gregory - 17 Sep 2025 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)
- Reporting relationship
- Director
- Issuer ticker
- NRIX
- Reported as of
- 17 Sep 2025
- Net transaction value
- +$19,995
- SEC form
- 4
- Accepted by SEC
- 17 Sep 2025, 18:58:07 UTC
- Prior SEC filing
- 19 May 2025
- Next SEC filing
- 30 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel Burbach, as Attorney-in-Fact for Julia P. Gregory
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Julia P. Gregory filed Form 4 for Nurix Therapeutics, Inc. (NRIX) on 17 Sep 2025.
Change
- Previous filing in this sequence was filed on 19 May 2025.
- Current net transaction value: +$19,995.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001226675
Primary reporting owner
GREGORY JULIA P
- Relationship
- Director
- Address
- C/O NURIX THERAPEUTICS, INC., 1700 OWENS STREET, SUITE 205, SAN FRANCISCO
- Signature
- /s/ Daniel Burbach, as Attorney-in-Fact for Julia P. Gregory
- Signature date
- 17 Sep 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NRIX
transaction
Common Stock
Options Exercise
- Transaction value
- $19,995
- Shares
- +10,750
- Change %
- Price
- $1.86
- Shares after
- 10,750
- Date
- 17 Sep 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NRIX
transaction
Derivative
Director Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -10,750
- Change %
- -32%
- Price
- $0.000000
- Shares after
- 22,583
- Date
- 17 Sep 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,750
- Exercise price
- $1.86
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock option vested as to 1/48 of the total shares monthly beginning September 12, 2019, and was vested in full on August 12, 2023.